| 1 |
33074119 | Design, synthesis and molecular modeling studies of 2-styrylquinazoline derivatives as EGFR inhibitors and apoptosis inducers. | 2020 Dec |
1 |
| 2 |
26829280 | Novel 4-anilinoquinazoline derivatives featuring an 1-adamantyl moiety as potent EGFR inhibitors with enhanced activity against NSCLC cell lines. | 2016 Mar 3 |
2 |
| 3 |
27102572 | EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen. | 2016 Jul |
1 |
| 4 |
27983649 | Design and Synthesis of Vandetanib Derivatives Containing Nitroimidazole Groups as Tyrosine Kinase Inhibitors in Normoxia and Hypoxia. | 2016 Dec 14 |
1 |
| 5 |
24269511 | Novel 2-chloro-4-anilino-quinazoline derivatives as EGFR and VEGFR-2 dual inhibitors. | 2014 Jan |
1 |
| 6 |
25305687 | Optimization of gefitinib analogues with potent anticancer activity. | 2014 Nov 15 |
1 |
| 7 |
22867529 | Synthesis, characterization, screening and docking analysis of 4-anilinoquinazoline derivatives as tyrosine kinase inhibitors. | 2013 Mar |
2 |
| 8 |
21177105 | Novel pyrrolo[2,1-f][1,2,4]triazin-4-amines: Dual inhibitors of EGFR and HER2 protein tyrosine kinases. | 2011 Jan 15 |
1 |
| 9 |
19208477 | Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitors. | 2009 Mar 1 |
2 |